U.S. FDA approves GlaxoSmithKline's blood cancer drug
- ByReuters-
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's (L:GSK) experimental treatment for a common form of blood cancer. GSK's belantamab...